- Report
- November 2024
- 450 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- March 2025
- 490 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- March 2025
- 650 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- March 2025
- 828 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- July 2024
- 113 Pages
Global
From €4235EUR$4,455USD£3,558GBP
€4706EUR$4,950USD£3,953GBP
- Report
- October 2024
- 199 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 199 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 196 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- October 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 138 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2024
- 136 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2024
- 142 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- February 2025
- 135 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- March 2025
- 436 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 196 Pages
Global
From €4706EUR$4,950USD£3,953GBP

The Cancer Genetics market is a subset of the Genomics market, focusing on the study of genetic mutations associated with cancer. This includes the identification of genetic markers that can be used to diagnose, monitor, and treat cancer. It also includes the development of targeted therapies and personalized medicine. Cancer Genetics research is conducted through a variety of methods, such as sequencing, bioinformatics, and gene expression analysis.
The Cancer Genetics market is driven by the increasing prevalence of cancer, advances in technology, and the growing demand for personalized medicine. Additionally, the increasing availability of genomic data and the development of new technologies are expected to drive the market in the future.
Some companies in the Cancer Genetics market include Illumina, Thermo Fisher Scientific, BGI, QIAGEN, and Agilent Technologies. Show Less Read more